This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kohno, M. Articles by Takeda, T. Search for Related Content PubMed PubMed Citation Articles by Kohno, M. Articles by Takeda, T.

Hypertension, Vol 18, 93-100, Copyright © 1991 by American Heart Association

ARTICLES

Plasma immunoreactive endothelin-1 in experimental malignant hypertension

M Kohno, K Murakawa, T Horio, K Yokokawa, K Yasunari, T Fukui and T Takeda
First Department of Internal Medicine, Osaka City University Medical School, Japan.

We measured plasma concentrations of immunoreactive endothelin-1 (irET- 1) in the prehypertensive and hypertensive phases in spontaneously hypertensive rats (SHR) and in malignant hypertension caused by deoxycorticosterone acetate (DOCA)-salt administration in SHR. We also measured concentrations of this peptide in another model of malignant hypertension, the two-kidney, one clip (2K1C) renovascular hypertensive rats chronically given caffeine. Plasma irET-1 concentrations in young (6-week-old) and mature (18-week-old) SHR did not differ from those of age-matched Wistar-Kyoto (WKY) rats. Four weeks of treatment with DOCA- salt increased blood pressure, blood urea nitrogen, serum creatinine, and plasma irET-1 in SHR but not in WKY rats. Eight weeks of DOCA-salt treatment further increased these values in SHR. Plasma irET-1 concentrations were not increased in the 2K1C rats. Six weeks of caffeine administration increased blood pressure, blood urea nitrogen, serum creatinine, plasma renin activity, and plasma irET-1 in the 2K1C rats but not in the sham-operated rats. High-performance liquid chromatographic profiles of plasma extracts pooled from these rats with malignant hypertension showed that a major component of irET-1 eluted in the position of synthetic ET-1 (1-21). Furthermore, acute hypertension induced by angiotensin II or phenylephrine did not affect the plasma irET-1 concentration in rats. The results suggested that the plasma ET-1 concentration is increased in rat models of malignant hypertension and that the high blood pressure itself is not the main factor involved in the increase of plasma ET-1.

This article has been cited by other articles:

				H. Wang, A. F. Chen, S. W. Watts, J. J. Galligan, and G. D. Fink Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H729 - H736. [Abstract] [Full Text] [PDF]

				G. R. Lee, D. Bell, E. J. Kelso, C. C. H. Argent, and B. J. McDermott Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H425 - H432. [Abstract] [Full Text] [PDF]

				C. K. Kost Jr., W. A. Herzer, B. R. Rominski, Z. Mi, and E. K. Jackson Diuretic Response to Adenosine A1 Receptor Blockade in Normotensive and Spontaneously Hypertensive Rats: Role of Pertussis Toxin-Sensitive G-Proteins J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 752 - 760. [Abstract] [Full Text]

				J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]

				E. Wilson, F. Vives, T. Collins, and H. E. Ives Strain-Responsive Regions in the Platelet-Derived Growth Factor-A Gene Promoter Hypertension, January 1, 1998; 31(1): 170 - 175. [Abstract] [Full Text] [PDF]

				T. Disashi, H. Nonoguchi, T. Iwaoka, S. Naomi, Y. Nakayama, K. Shimada, K. Tanzawa, and K. Tomita Endothelin Converting Enzyme-1 Gene Expression in the Kidney of Spontaneously Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1591 - 1597. [Abstract] [Full Text]

				C. R. Aversa, S. Oparil, J. Caro, H. Li, S.-D. Sun, Y.-F. Chen, M. R. Swerdel, T. M. Monticello, S. K. Durham, A. Minchenko, et al. Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L848 - L855. [Abstract] [Full Text] [PDF]

				K. A. H. Kaasjager, H. A. Koomans, and T. J. Rabelink Endothelin-1–Induced Vasopressor Responses in Essential Hypertension Hypertension, July 1, 1997; 30(1): 15 - 21. [Abstract] [Full Text]

				C. E. Whitworth, M. M. Veniant, J. D. Firth, A. D. Cumming, and J. J. Mullins Endothelin in the Kidney in Malignant Phase Hypertension Hypertension, December 1, 1995; 26(6): 925 - 931. [Abstract] [Full Text]

				E. L. Schiffrin Endothelin: Potential Role in Hypertension and Vascular Hypertrophy Hypertension, June 1, 1995; 25(6): 1135 - 1143. [Abstract] [Full Text]

				M. Kohno, H. Kano, T. Horio, K. Yokokawa, K. Yasunari, and T. Takeda Inhibition of Endothelin Production by Adrenomedullin in Vascular Smooth Muscle Cells Hypertension, June 1, 1995; 25(6): 1185 - 1190. [Abstract] [Full Text]

				M. Ikeda, M. Kohno, and T. Takeda Endothelin Production in Cultured Mesangial Cells of Spontaneously Hypertensive Rats Hypertension, June 1, 1995; 25(6): 1196 - 1201. [Abstract] [Full Text]

				M. Ikeda, M. Kohno, and T. Takeda Endothelin Production in Cultured Mesangial Cells of Spontaneously Hypertensive Rats Hypertension, April 1, 1995; 25(4): 1 - 6. [Abstract] [Full Text]

				K. Hishikawa, T. Nakaki, T. Marumo, H. Suzuki, R. Kato, and T. Saruta Pressure Enhances Endothelin-1 Release From Cultured Human Endothelial Cells Hypertension, March 1, 1995; 25(3): 449 - 452. [Abstract] [Full Text]